According to clinical trial results, users of tirzepatide had nearly a threefold higher risk of gastrointestinal issues, while users of semaglutide had less than a twofold higher risk compared to those receiving a placebo
Pregnant or breastfeeding individuals should consult with their healthcare provider before using this medication
However, most of the PK studies demonstrated that the absorption characteristics of the oral drugs were not affected, therefore unsurprisingly, the co-exposure to a GLP1RA did not alter the AUC
Everyone responds differently to semaglutide, and your optimal food list will be unique to you
[1] While semaglutide itself doesn't typically cause frequent urination, certain urinary symptoms warrant prompt medical evaluation
Clinicians also evaluate lab trends, medications, and weight-related complications